Advanced search
Publication Cover
Ocular Immunology and Inflammation Latest Articles
Submit an article Journal homepage
52
Views
0
CrossRef citations to date
0
Altmetric
Brief Report

Resolution of Postoperative Cystoid Macular Edema with a Suprachoroidal Triamcinolone Acetonide Injectable Suspension

Justin Hansona UCLA Department of Ophthalmology, Jules Stein Eye Institute, Los Angeles, California, USAORCID Iconhttps://orcid.org/0000-0002-5647-7954View further author information
, BAORCID Icon,
David Hsua UCLA Department of Ophthalmology, Jules Stein Eye Institute, Los Angeles, California, USAView further author information
, MD,
Shani Pillara UCLA Department of Ophthalmology, Jules Stein Eye Institute, Los Angeles, California, USAView further author information
, MD,
Edmund Tsuia UCLA Department of Ophthalmology, Jules Stein Eye Institute, Los Angeles, California, USAORCID Iconhttps://orcid.org/0000-0001-7532-9191View further author information
, MDORCID Icon &
Irena Tsuia UCLA Department of Ophthalmology, Jules Stein Eye Institute, Los Angeles, California, USA;b Division of Ophthalmology, VA Greater Los Angeles Healthcare System, Los Angeles, California, USACorrespondence[email protected]
View further author information
, MD
Received 03 Apr 2024, Accepted 13 May 2024, Published online: 23 May 2024

References

  • Iftikhar M, Dun C, Schein OD, Lum F, Woreta F. Cystoid macular edema after cataract surgery in the United States: IRIS® Registry (Intelligent research in sight) analysis. Ophthalmology. 2023;130(10):1005–1014. doi: 10.1016/j.ophtha.2023.06.001. PMID: 37302490.
  • Benitah NR, Arroyo JG. Pseudophakic cystoid macular edema. Int Ophthalmol Clin. 2010;50(1):139–153. doi: 10.1097/IIO.0b013e3181c551da. PMID: 20057303
  • Karim R, Sykakis E, Lightman S, Fraser-Bell S. Interventions for the treatment of uveitic macular edema: a systematic review and meta-analysis. Clin Ophthalmol. 2013;7:1109–1144. doi: 10.2147/OPTH.S40268. PMID: 23807831.
  • Valdes LM, Sobrin L. Uveitis therapy: the corticosteroid options. Drugs. 2020;80(8):765–773. doi: 10.1007/s40265-020-01314-y. PMID: 32350761.
  • James ER. The etiology of steroid cataract. J Ocul Pharmacol Ther. 2007;23(5):403–420. doi: 10.1089/jop.2006.0067. PMID: 17900234
  • Muya L, Kansara V, Cavet ME, Ciulla T. Suprachoroidal injection of triamcinolone acetonide suspension: ocular pharmacokinetics and distribution in rabbits demonstrates high and durable levels in the chorioretina. J Ocul Pharmacol Ther. 2022;38(6):459–467. doi: 10.1089/jop.2021.0090. PMID: 35404132.
  • Clearside Biomedical. XIPERE® (triamcinolone acetonide injectable suspension), for suprachoroidal use: US prescribing information. 2021. https://www.xipere.com/. Accessed March 13, 2024.
  • Yeh S, Khurana RN, Shah M, Henry CR, Wang RC, Kissner JM, et al. PEACHTREE study investigators. Efficacy and safety of suprachoroidal CLS-TA for macular edema secondary to noninfectious uveitis: phase 3 randomized trial. Ophthalmology. 2020;127(7):948–955. doi: 10.1016/j.ophtha.2020.01.006. PMID: 32173113.
  • Khurana RN, Merrill P, Yeh S, Suhler E, Barakat MR, Uchiyama E, et al. Extension study of the safety and efficacy of CLS-TA for treatment of macular oedema associated with non-infectious uveitis (MAGNOLIA). Br J Ophthalmol. 2022;106(8):1139–1144. doi: 10.1136/bjophthalmol-2020-317560. PMID: 33712478.
  • Goldstein DA, Do D, Noronha G, Kissner JM, Srivastava SK, Nguyen QD. Suprachoroidal corticosteroid administration: a novel route for local treatment of noninfectious uveitis. Transl Vis Sci Technol. 2016;5(6):14. doi: 10.1167/tvst.5.6.14. PMID: 27980877
  • Yeh S, Kurup SK, Wang RC, Foster CS, Noronha G, Nguyen QD, et al. Suprachoroidal injection of triamcinolone acetonide, CLS-TA, for macular edema due to noninfectious uveitis: a randomized, phase 2 study (DOGWOOD). Retina. 2019;39(10):1880–1888. doi: 10.1097/IAE.0000000000002279. PMID: 30113933
  • Conway MD, Canakis C, Livir-Rallatos C, Peyman GA. Intravitreal triamcinolone acetonide for refractory chronic pseudophakic cystoid macular edema. J Cataract Refract Surg. 2003;29(1):27–33. doi: 10.1016/s0886-3350(02)01441-4. PMID: 12551663
  • Arevalo JF, Garcia-Amaris RA, Roca JA, Sanchez JG, Wu L, Berrocal MH, et al. Primary intravitreal bevacizumab for the management of pseudophakic cystoid macular edema: pilot study of the Pan-American Collaborative Retina Study Group. J Cataract Refract Surg. 2007;33(12):2098–2105. doi: 10.1016/j.jcrs.2007.07.046. PMID: 18053911.
  • Barone A, Russo V, Prascina F, Delle Noci N. Short-term safety and efficacy of intravitreal bevacizumab for pseudophakic cystoid macular edema. Retina. 2009;29(1):33–37. doi: 10.1097/IAE.0b013e31818a1fbc. PMID: 18854783.
  • Khurana RN, Appa SN, Ca M, Elman MJ, Wittenberg SE, Parks DJ, et al. Dexamethasone implant anterior chamber migration: risk factors, complications, and management strategies. Ophthalmology. 2014;121(1):67–71. doi: 10.1016/j.ophtha.2013.06.033. PMID: 23890421

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.